Glen Eagle Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-40
Closed -$6.08K 861
2019
Q2
$6.08K Buy
+40
New +$6.08K ﹤0.01% 593